Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Hearing Disorders: HELP
Articles by Deena B. Hollingsworth
Based on 5 articles published since 2009
(Why 5 articles?)
||||

Between 2009 and 2019, Deena Hollingsworth wrote the following 5 articles about Hearing Disorders.
 
+ Citations + Abstracts
1 Guideline Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). 2017

Bhattacharyya, Neil / Gubbels, Samuel P / Schwartz, Seth R / Edlow, Jonathan A / El-Kashlan, Hussam / Fife, Terry / Holmberg, Janene M / Mahoney, Kathryn / Hollingsworth, Deena B / Roberts, Richard / Seidman, Michael D / Steiner, Robert W Prasaad / Do, Betty Tsai / Voelker, Courtney C J / Waguespack, Richard W / Corrigan, Maureen D. ·1 Department of Otolaryngology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA. · 2 Department of Otolaryngology, School of Medicine and Public Health, University of Colorado, Aurora, Colorado, USA. · 3 Department of Otolaryngology, Virginia Mason Medical Center, Seattle, Washington, USA. · 4 Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. · 5 Department of Otolaryngology, University of Michigan, Ann Arbor, Michigan, USA. · 6 Barrow Neurological Institute and College of Medicine, University of Arizona, Phoenix, Arizona, USA. · 7 Intermountain Hearing and Balance Center, Salt Lake City, Utah, USA. · 8 Vestibular Disorders Association, Portland, Oregon, USA. · 9 Ear, Nose & Throat Specialists of Northern Virginia, PC, Arlington, Virginia, USA. · 10 Alabama Hearing and Balance Associates, Inc, Birmingham, Alabama, USA. · 11 Department of Otolaryngology-Head and Neck Surgery, College of Medicine, University of Central Florida, Orlando, Florida, USA. · 12 Department of Health Management and Systems Science and Department of Family and Geriatric Medicine, School of Public Health and Information Science, University of Louisville, Louisville, Kentucky, USA. · 13 Department of Otorhinolaryngology, Health Sciences Center, University of Oklahoma, Oklahoma City, Oklahoma, USA. · 14 Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · 15 Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama, USA. · 16 American Academy of Otolaryngology-Head and Neck Surgery Foundation, Alexandria, Virginia, USA. ·Otolaryngol Head Neck Surg · Pubmed #28248609.

ABSTRACT: Objective This update of a 2008 guideline from the American Academy of Otolaryngology-Head and Neck Surgery Foundation provides evidence-based recommendations to benign paroxysmal positional vertigo (BPPV), defined as a disorder of the inner ear characterized by repeated episodes of positional vertigo. Changes from the prior guideline include a consumer advocate added to the update group; new evidence from 2 clinical practice guidelines, 20 systematic reviews, and 27 randomized controlled trials; enhanced emphasis on patient education and shared decision making; a new algorithm to clarify action statement relationships; and new and expanded recommendations for the diagnosis and management of BPPV. Purpose The primary purposes of this guideline are to improve the quality of care and outcomes for BPPV by improving the accurate and efficient diagnosis of BPPV, reducing the inappropriate use of vestibular suppressant medications, decreasing the inappropriate use of ancillary testing such as radiographic imaging, and increasing the use of appropriate therapeutic repositioning maneuvers. The guideline is intended for all clinicians who are likely to diagnose and manage patients with BPPV, and it applies to any setting in which BPPV would be identified, monitored, or managed. The target patient for the guideline is aged ≥18 years with a suspected or potential diagnosis of BPPV. The primary outcome considered in this guideline is the resolution of the symptoms associated with BPPV. Secondary outcomes considered include an increased rate of accurate diagnoses of BPPV, a more efficient return to regular activities and work, decreased use of inappropriate medications and unnecessary diagnostic tests, reduction in recurrence of BPPV, and reduction in adverse events associated with undiagnosed or untreated BPPV. Other outcomes considered include minimizing costs in the diagnosis and treatment of BPPV, minimizing potentially unnecessary return physician visits, and maximizing the health-related quality of life of individuals afflicted with BPPV. Action Statements The update group made strong recommendations that clinicians should (1) diagnose posterior semicircular canal BPPV when vertigo associated with torsional, upbeating nystagmus is provoked by the Dix-Hallpike maneuver, performed by bringing the patient from an upright to supine position with the head turned 45° to one side and neck extended 20° with the affected ear down, and (2) treat, or refer to a clinician who can treat, patients with posterior canal BPPV with a canalith repositioning procedure. The update group made a strong recommendation against postprocedural postural restrictions after canalith repositioning procedure for posterior canal BPPV. The update group made recommendations that the clinician should (1) perform, or refer to a clinician who can perform, a supine roll test to assess for lateral semicircular canal BPPV if the patient has a history compatible with BPPV and the Dix-Hallpike test exhibits horizontal or no nystagmus; (2) differentiate, or refer to a clinician who can differentiate, BPPV from other causes of imbalance, dizziness, and vertigo; (3) assess patients with BPPV for factors that modify management, including impaired mobility or balance, central nervous system disorders, a lack of home support, and/or increased risk for falling; (4) reassess patients within 1 month after an initial period of observation or treatment to document resolution or persistence of symptoms; (5) evaluate, or refer to a clinician who can evaluate, patients with persistent symptoms for unresolved BPPV and/or underlying peripheral vestibular or central nervous system disorders; and (6) educate patients regarding the impact of BPPV on their safety, the potential for disease recurrence, and the importance of follow-up. The update group made recommendations against (1) radiographic imaging for a patient who meets diagnostic criteria for BPPV in the absence of additional signs and/or symptoms inconsistent with BPPV that warrant imaging, (2) vestibular testing for a patient who meets diagnostic criteria for BPPV in the absence of additional vestibular signs and/or symptoms inconsistent with BPPV that warrant testing, and (3) routinely treating BPPV with vestibular suppressant medications such as antihistamines and/or benzodiazepines. The guideline update group provided the options that clinicians may offer (1) observation with follow-up as initial management for patients with BPPV and (2) vestibular rehabilitation, either self-administered or with a clinician, in the treatment of BPPV.

2 Guideline Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update) Executive Summary. 2017

Bhattacharyya, Neil / Gubbels, Samuel P / Schwartz, Seth R / Edlow, Jonathan A / El-Kashlan, Hussam / Fife, Terry / Holmberg, Janene M / Mahoney, Kathryn / Hollingsworth, Deena B / Roberts, Richard / Seidman, Michael D / Prasaad Steiner, Robert W / Tsai Do, Betty / Voelker, Courtney C J / Waguespack, Richard W / Corrigan, Maureen D. ·1 Department of Otolaryngology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA. · 2 Department of Otolaryngology, School of Medicine and Public Health, University of Colorado, Aurora, Colorado, USA. · 3 Department of Otolaryngology, Virginia Mason Medical Center, Seattle, Washington, USA. · 4 Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. · 5 Department of Otolaryngology, University of Michigan, Ann Arbor, Michigan, USA. · 6 Barrow Neurological Institute and College of Medicine, University of Arizona, Phoenix, Arizona, USA. · 7 Intermountain Hearing and Balance Center, Salt Lake City, Utah, USA. · 8 Vestibular Disorders Association, Portland, Oregon, USA. · 9 Ear, Nose & Throat Specialists of Northern Virginia, PC, Arlington, Virginia, USA. · 10 Alabama Hearing and Balance Associates, Inc, Birmingham, Alabama, USA. · 11 Department of Otolaryngology-Head and Neck Surgery, College of Medicine, University of Central Florida, Orlando, Florida, USA. · 12 Department of Health Management and Systems Science and Department of Family and Geriatric Medicine, School of Public Health and Information Science, University of Louisville, Louisville, Kentucky, USA. · 13 Department of Otorhinolaryngology, Health Sciences Center, University of Oklahoma, Oklahoma City, Oklahoma, USA. · 14 Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · 15 Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama, USA. · 16 American Academy of Otolaryngology-Head and Neck Surgery Foundation, Alexandria, Virginia, USA. ·Otolaryngol Head Neck Surg · Pubmed #28248602.

ABSTRACT: The American Academy of Otolaryngology-Head and Neck Surgery Foundation has published a supplement to this issue of Otolaryngology-Head and Neck Surgery featuring the "Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update)." To assist in implementing the guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 14 recommendations developed emphasize diagnostic accuracy and efficiency, reducing the inappropriate use of vestibular suppressant medications, decreasing the inappropriate use of ancillary testing, and increasing the appropriate therapeutic repositioning maneuvers. An updated guideline is needed due to new clinical trials, new systematic reviews, and the lack of consumer participation in the initial guideline development group.

3 Guideline Clinical practice guideline: tinnitus executive summary. 2014

Tunkel, David E / Bauer, Carol A / Sun, Gordon H / Rosenfeld, Richard M / Chandrasekhar, Sujana S / Cunningham, Eugene R / Archer, Sanford M / Blakley, Brian W / Carter, John M / Granieri, Evelyn C / Henry, James A / Hollingsworth, Deena / Khan, Fawad A / Mitchell, Scott / Monfared, Ashkan / Newman, Craig W / Omole, Folashade S / Phillips, C Douglas / Robinson, Shannon K / Taw, Malcolm B / Tyler, Richard S / Waguespack, Richard / Whamond, Elizabeth J. ·Otolaryngology-Head and Neck Surgery, Johns Hopkins Outpatient Center, Baltimore, Maryland, USA dtunkel@jhmi.edu. · Division of Otolaryngology-Head and Neck Surgery, Southern Illinois University School of Medicine, Springfield, Illinois, USA. · Partnership for Health Analytic Research, LLC, Los Angeles, California, USA. · Department of Otolaryngology, State University of New York Downstate Medical Center, Brooklyn, New York, USA. · New York Otology, New York, New York, USA. · Department of Research and Quality Improvement, American Academy of Otolaryngology-Head and Neck Surgery Foundation, Alexandria, Virginia, USA. · Divisions of Rhinology & Sinus Surgery and Facial Plastic & Reconstructive Surgery, University of Kentucky, Lexington, Kentucky, USA. · Department of Otolaryngology, University of Manitoba, Winnipeg, MB, Canada. · Department of Otolaryngology, Tulane University, New Orleans, Louisiana, USA. · Division of Geriatric Medicine and Aging, Columbia University, New York, New York, USA. · National Center for Rehabilitative Auditory Research, Portland VA Medical Center, Portland, Oregon, USA. · ENT Specialists of Northern Virginia, Falls Church, Virginia, USA. · Ochsner Health System, Kenner, Louisiana, USA. · Mitchell & Cavallo, P.C., Houston, Texas, USA. · Department of Otology and Neurotology, The George Washington University, Washington, DC, USA. · Department of Surgery, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA. · Morehouse School of Medicine, East Point, Georgia, USA. · Department of Head and Neck Imaging, Weill Cornell Medical Center, NewYork-Presbyterian Hospital, New York, New York, USA. · Department of Psychiatry, University of California, San Diego, La Jolla, California, USA. · Department of Medicine, UCLA Center for East-West Medicine, Los Angeles, California, USA. · Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA. · Department of Surgery, University of Alabama School of Medicine, Birmingham, Alabama, USA. · Consumers United for Evidence-based Healthcare, Fredericton, New Brunswick, Canada. ·Otolaryngol Head Neck Surg · Pubmed #25274374.

ABSTRACT: The American Academy of Otolaryngology--Head and Neck Surgery Foundation (AAO-HNSF) has published a supplement to this issue featuring the new Clinical Practice Guideline: Tinnitus. To assist in implementing the guideline recommendations, this article summarizes the rationale, purpose, and key action statements. The 13 recommendations developed address the evaluation of patients with tinnitus, including selection and timing of diagnostic testing and specialty referral to identify potential underlying treatable pathology. It will then focus on the evaluation and treatment of patients with persistent primary tinnitus, with recommendations to guide the evaluation and measurement of the impact of tinnitus and to determine the most appropriate interventions to improve symptoms and quality of life for tinnitus sufferers.

4 Guideline Clinical practice guideline: sudden hearing loss. 2012

Stachler, Robert J / Chandrasekhar, Sujana S / Archer, Sanford M / Rosenfeld, Richard M / Schwartz, Seth R / Barrs, David M / Brown, Steven R / Fife, Terry D / Ford, Peg / Ganiats, Theodore G / Hollingsworth, Deena B / Lewandowski, Christopher A / Montano, Joseph J / Saunders, James E / Tucci, Debara L / Valente, Michael / Warren, Barbara E / Yaremchuk, Kathleen L / Robertson, Peter J / Anonymous4970719. ·Department of Otolaryngology, Henry Ford Hospital, Detroit, Michigan 48202, USA. rstachl1@hfhs.org ·Otolaryngol Head Neck Surg · Pubmed #22383545.

ABSTRACT: OBJECTIVE: Sudden hearing loss (SHL) is a frightening symptom that often prompts an urgent or emergent visit to a physician. This guideline provides evidence-based recommendations for the diagnosis, management, and follow-up of patients who present with SHL. The guideline primarily focuses on sudden sensorineural hearing loss (SSNHL) in adult patients (aged 18 and older). Prompt recognition and management of SSNHL may improve hearing recovery and patient quality of life (QOL). Sudden sensorineural hearing loss affects 5 to 20 per 100,000 population, with about 4000 new cases per year in the United States. This guideline is intended for all clinicians who diagnose or manage adult patients who present with SHL. PURPOSE: The purpose of this guideline is to provide clinicians with evidence-based recommendations in evaluating patients with SHL, with particular emphasis on managing SSNHL. The panel recognized that patients enter the health care system with SHL as a nonspecific, primary complaint. Therefore, the initial recommendations of the guideline deal with efficiently distinguishing SSNHL from other causes of SHL at the time of presentation. By focusing on opportunities for quality improvement, the guideline should improve diagnostic accuracy, facilitate prompt intervention, decrease variations in management, reduce unnecessary tests and imaging procedures, and improve hearing and rehabilitative outcomes for affected patients. RESULTS: The panel made strong recommendations that clinicians should (1) distinguish sensorineural hearing loss from conductive hearing loss in a patient presenting with SHL; (2) educate patients with idiopathic sudden sensorineural hearing loss (ISSNHL) about the natural history of the condition, the benefits and risks of medical interventions, and the limitations of existing evidence regarding efficacy; and (3) counsel patients with incomplete recovery of hearing about the possible benefits of amplification and hearing-assistive technology and other supportive measures. The panel made recommendations that clinicians should (1) assess patients with presumptive SSNHL for bilateral SHL, recurrent episodes of SHL, or focal neurologic findings; (2) diagnose presumptive ISSNHL if audiometry confirms a 30-dB hearing loss at 3 consecutive frequencies and an underlying condition cannot be identified by history and physical examination; (3) evaluate patients with ISSNHL for retrocochlear pathology by obtaining magnetic resonance imaging, auditory brainstem response, or audiometric follow-up; (4) offer intratympanic steroid perfusion when patients have incomplete recovery from ISSNHL after failure of initial management; and (5) obtain follow-up audiometric evaluation within 6 months of diagnosis for patients with ISSNHL. The panel offered as options that clinicians may offer (1) corticosteroids as initial therapy to patients with ISSNHL and (2) hyperbaric oxygen therapy within 3 months of diagnosis of ISSNHL. The panel made a recommendation against clinicians routinely prescribing antivirals, thrombolytics, vasodilators, vasoactive substances, or antioxidants to patients with ISSNHL. The panel made strong recommendations against clinicians (1) ordering computerized tomography of the head/brain in the initial evaluation of a patient with presumptive SSNHL and (2) obtaining routine laboratory tests in patients with ISSNHL.

5 Article Clinical practice guideline: tinnitus. 2014

Tunkel, David E / Bauer, Carol A / Sun, Gordon H / Rosenfeld, Richard M / Chandrasekhar, Sujana S / Cunningham, Eugene R / Archer, Sanford M / Blakley, Brian W / Carter, John M / Granieri, Evelyn C / Henry, James A / Hollingsworth, Deena / Khan, Fawad A / Mitchell, Scott / Monfared, Ashkan / Newman, Craig W / Omole, Folashade S / Phillips, C Douglas / Robinson, Shannon K / Taw, Malcolm B / Tyler, Richard S / Waguespack, Richard / Whamond, Elizabeth J. ·Otolaryngology-Head and Neck Surgery, Johns Hopkins Outpatient Center, Baltimore, Maryland, USA dtunkel@jhmi.edu. · Division of Otolaryngology-Head and Neck Surgery, Southern Illinois University School of Medicine, Springfield, Illinois, USA. · Partnership for Health Analytic Research, LLC, Los Angeles, California, USA. · Department of Otolaryngology, State University of New York at Downstate Medical Center, Brooklyn, New York, USA. · New York Otology, New York, New York, USA. · Department of Research and Quality Improvement, American Academy of Otolaryngology-Head and Neck Surgery Foundation, Alexandria, Virginia, USA. · Divisions of Rhinology & Sinus Surgery and Facial Plastic & Reconstructive Surgery, University of Kentucky, Lexington, Kentucky, USA. · Department of Otolaryngology, University of Manitoba, Winnipeg, Manitoba, Canada. · Department of Otolaryngology, Tulane University, New Orleans, Louisiana, USA. · Division of Geriatric Medicine and Aging, Columbia University, New York, New York, USA. · National Center for Rehabilitative Auditory Research, Portland VA Medical Center, Portland, Oregon, USA. · ENT Specialists of Northern Virginia, Falls Church, Virginia, USA. · Ochsner Health System, Kenner, Louisiana, USA. · Mitchell & Cavallo, P.C., Houston, Texas, USA. · Department of Otology and Neurotology, The George Washington University, Washington, DC, USA. · Department of Surgery, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA. · Morehouse School of Medicine, East Point, Georgia, USA. · Department of Head and Neck Imaging, Weill Cornell Medical Center, New York-Presbyterian Hospital, New York, New York, USA. · Department of Psychiatry, University of California, San Diego, La Jolla, California, USA. · Department of Medicine, UCLA Center for East-West Medicine, Los Angeles, California, USA. · Department of Otolaryngology-Head and Neck Surgery, The University of Iowa, Iowa City, Iowa, USA. · Department of Surgery, University of Alabama School of Medicine, Birmingham, Alabama, USA. · Consumers United for Evidence-Based Healthcare, Fredericton, New Brunswick, Canada. ·Otolaryngol Head Neck Surg · Pubmed #25273878.

ABSTRACT: OBJECTIVE: Tinnitus is the perception of sound without an external source. More than 50 million people in the United States have reported experiencing tinnitus, resulting in an estimated prevalence of 10% to 15% in adults. Despite the high prevalence of tinnitus and its potential significant effect on quality of life, there are no evidence-based, multidisciplinary clinical practice guidelines to assist clinicians with management. The focus of this guideline is on tinnitus that is both bothersome and persistent (lasting 6 months or longer), which often negatively affects the patient's quality of life. The target audience for the guideline is any clinician, including nonphysicians, involved in managing patients with tinnitus. The target patient population is limited to adults (18 years and older) with primary tinnitus that is persistent and bothersome. PURPOSE: The purpose of this guideline is to provide evidence-based recommendations for clinicians managing patients with tinnitus. This guideline provides clinicians with a logical framework to improve patient care and mitigate the personal and social effects of persistent, bothersome tinnitus. It will discuss the evaluation of patients with tinnitus, including selection and timing of diagnostic testing and specialty referral to identify potential underlying treatable pathology. It will then focus on the evaluation and treatment of patients with persistent primary tinnitus, with recommendations to guide the evaluation and measurement of the effect of tinnitus and to determine the most appropriate interventions to improve symptoms and quality of life for tinnitus sufferers. ACTION STATEMENTS: The development group made a strong recommendation that clinicians distinguish patients with bothersome tinnitus from patients with nonbothersome tinnitus. The development group made a strong recommendation against obtaining imaging studies of the head and neck in patients with tinnitus, specifically to evaluate tinnitus that does not localize to 1 ear, is nonpulsatile, and is not associated with focal neurologic abnormalities or an asymmetric hearing loss. The panel made the following recommendations: Clinicians should (a) perform a targeted history and physical examination at the initial evaluation of a patient with presumed primary tinnitus to identify conditions that if promptly identified and managed may relieve tinnitus; (b) obtain a prompt, comprehensive audiologic examination in patients with tinnitus that is unilateral, persistent (≥ 6 months), or associated with hearing difficulties; (c) distinguish patients with bothersome tinnitus of recent onset from those with persistent symptoms (≥ 6 months) to prioritize intervention and facilitate discussions about natural history and follow-up care; (d) educate patients with persistent, bothersome tinnitus about management strategies; (e) recommend a hearing aid evaluation for patients who have persistent, bothersome tinnitus associated with documented hearing loss; and (f) recommend cognitive behavioral therapy to patients with persistent, bothersome tinnitus. The panel recommended against (a) antidepressants, anticonvulsants, anxiolytics, or intratympanic medications for the routine treatment of patients with persistent, bothersome tinnitus; (b) Ginkgo biloba, melatonin, zinc, or other dietary supplements for treating patients with persistent, bothersome tinnitus; and (c) transcranial magnetic stimulation for the routine treatment of patients with persistent, bothersome tinnitus. The development group provided the following options: Clinicians may (a) obtain an initial comprehensive audiologic examination in patients who present with tinnitus (regardless of laterality, duration, or perceived hearing status); and (b) recommend sound therapy to patients with persistent, bothersome tinnitus. The development group provided no recommendation regarding the effect of acupuncture in patients with persistent, bothersome tinnitus.